0001178913-24-000818 Sample Contracts
LICENSE AGREEMENT between Compugen Ltd. and Gilead Sciences, Inc. dated December 18, 2023License Agreement • March 5th, 2024 • Compugen LTD • Biological products, (no disgnostic substances) • New York
This License Agreement (“Agreement”), effective as of December 18, 2023 (the “Effective Date”), is entered into by and between Compugen Ltd., a limited liability company organized under the laws of Israel with a place of business at Azrieli Center, 26 Harokmim Street, Building D, Holon 5885849, Israel (“CGEN”), and Gilead Sciences, Inc., a Delaware corporation with a place of business at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”). CGEN and Gilead may be referred to herein individually as a “Party” or collectively as the “Parties”.
